Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-13

Clinical Trial Update: A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

A Phase 1 study comparing Tretinoin Gel Microsphere 0.04% and Retin-A Micro Gel Microsphere 0.04% for acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RETIN-A MICRO Gel Microsphere, 0.04% (tretinoin)
  • Tretinoin Gel Microsphere, 0.04% (tretinoin)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED